Veterinary Medicines

Adrestan 60 mg Hard Capsules

Authorised
  • Trilostane
Download as PDF

Identifikazzjoni tal-prodott

Isem tal-mediċina:
Adrestan 60 mg hard capsules
Adrestan 60 mg Hard Capsules
Sustanza attiva:
Speċi li fuqhom ser jintuża l-prodott:
Metodu ta’ amministrazzjoni:
  • Użu orali

Dettalji tal-prodott

Sustanza attiva / Qawwa:
  • Disponibbli biss fi English
    60.00
    milligram(s)
    /
    1.00
    Capsule
Forma farmaċewtika:
  • Kapsula, iebsa
Withdrawal period by route of administration:
  • Oral use
    • Dog
Kodiċi veterinarju anatomiku terapewtiku kimiku (ATCvet):
  • QH02CA01
Status legali tal-provvista:
Status tal-awtorizzazzjoni:
  • Valid
Authorised in:
  • United Kingdom (Northern Ireland)
Deskrizzjoni tal-pakkett:

Tagħrif addizzjonali

Entitlement type:
Bażi ġuridika tal-awtorizzazzjoni tal-prodott:
Id-detentur tal-awtorizzazzjoni għat-tqegħid fis-suq:
  • Dechra Limited
Marketing authorisation date:
Siti ta’ manifattura b’rilaxx tal-lott:
  • Dales Pharmaceuticals Limited
  • Genera d.d.
Awtorità responsabbli:
  • VMD
Numru tal-awtorizzazzjoni:
  • Vm 10434/4089
Data tal-bidla fl-istatus tal-awtorizzazzjoni:
Stat Membru ta’ referenza:
Numru tal-proċedura:
  • IE/V/0503/003
Stati Membri Kkonċernati:

Dokumenti

Sommarju tal-karatteristiċi tal-prodott

Dan id-dokument ma jeżistix f'dan il-lingwa (Malti). Tista 'ssibha f'lingwa oħra hawn taħt.
English (PDF)
Ippubblikat fuq: 11/02/2022
Niżżel
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."